Team approach to polypharmacy evaluation and reduction for general practice patients with dementia: the Australian TAPERDem study
Therapeutic Advances in Drug Safety
Published online on July 10, 2026
Abstract
Therapeutic Advances in Drug Safety, Volume 17, January-December 2026.
Background:Polypharmacy is common in people with dementia but may be insufficiently tailored to personal preferences and goals, particularly in the presence of a life-limiting condition.Objectives:To evaluate the effectiveness of pharmacists working with ...
Background:Polypharmacy is common in people with dementia but may be insufficiently tailored to personal preferences and goals, particularly in the presence of a life-limiting condition.Objectives:To evaluate the effectiveness of pharmacists working with ...